PleoPharma to Present New Cannabis Withdrawal Rese...
Category : Clinical Trial Update 16 June 2026PleoPharma has announced that it will present two scientific posters at the College on Problems of D...
Clinical Trial Update
Neurocrine Biosciences Shares New Long-Term Data f...
Category : Clinical Trial Update 16 June 2026Neurocrine Biosciences has announced new late-breaking data from the Phase 3 development program of...
Hillhurst Bio Doses First Patient in Phase 2a Tria...
Category : Clinical Trial Update 16 June 2026Hillhurst Biopharmaceuticals has announced an important milestone in its Parkinson’s disease p...
Celldex Reports Long-Term Phase 2 Data for Barzolv...
Category : Clinical Trial Update 16 June 2026Celldex Therapeutics has shared new long-term results from its Phase 2 study evaluating barzolvolima...
Mirum and Incyte Report Positive Phase 2 Results f...
Category : Clinical Trial Update 15 June 2026New Data Highlights Strong Disease Control in Patients with FOP Mirum Pharmaceuticals and Incyte...
Latest Newsletter Post
-
Celldex Reports Long-Term Phase 2 D..
16 June 2026
-
Hillhurst Bio Doses First Patient i..
16 June 2026
-
Neurocrine Biosciences Shares New L..
16 June 2026
-
PleoPharma to Present New Cannabis..
16 June 2026
-
Johnson & Johnson Expands TREMFYA A..
15 June 2026
